BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38062948)

  • 1. Grading medullary thyroid carcinoma on fine-needle aspiration cytology specimens with the International Medullary Thyroid Carcinoma Grading System: A cytologic-histologic correlation.
    Viswanathan K; Behrman DB; Lubin DJ
    Cancer Cytopathol; 2024 Apr; 132(4):224-232. PubMed ID: 38062948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent Validation of the International Grading System for Medullary Thyroid Carcinoma: A Single Institution Experience.
    Lubin DJ; Behrman DB; Goyal S; Magliocca K; Shi Q; Chen AY; Viswanathan K
    Mod Pathol; 2023 Sep; 36(9):100235. PubMed ID: 37270155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma.
    Xu B; Fuchs TL; Ahmadi S; Alghamdi M; Alzumaili B; Bani MA; Baudin E; Chou A; De Leo A; Fagin JA; Ganly I; Glover A; Hartl D; Kanaan C; Khneisser P; Najdawi F; Nigam A; Papachristos A; Repaci A; Spanheimer PM; Solaroli E; Untch BR; Barletta JA; Tallini G; Al Ghuzlan A; Gill AJ; Ghossein RA
    J Clin Oncol; 2022 Jan; 40(1):96-104. PubMed ID: 34731032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of Digital Image Analysis for Ki67 Quantification in the Grading of Medullary Thyroid Carcinoma: A Pilot Study with 85 Cases.
    Behrman DB; Lubin DJ; Magliocca K; Shi Q; Viswanathan K
    Head Neck Pathol; 2023 Sep; 17(3):638-646. PubMed ID: 37294412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grading of Medullary Thyroid Carcinoma: an Interobserver Reproducibility Study.
    Williams JF; Zhao M; Najdawi F; Ahmadi S; Hornick JL; Wong KS; Barletta JA
    Endocr Pathol; 2022 Sep; 33(3):371-377. PubMed ID: 35553368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External Validation of Three Available Grading Systems for Medullary Thyroid Carcinoma in a Single Institution Cohort.
    Vissio E; Maletta F; Fissore J; Osella Abate S; Retta F; Brizzi MP; Piovesan A; Rossetto Giaccherino R; Volante M; Papotti M
    Endocr Pathol; 2022 Sep; 33(3):359-370. PubMed ID: 35583706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International medullary thyroid carcinoma grading system: an Indian tertiary care centre experience.
    Rai V; Saha A; Mehta S; Shah RA; Trivedi P; Samanta ST; Rathod P; Manimaran P
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1571-1579. PubMed ID: 38010402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performing Calcitonin Immunocytochemistry on an Additional ThinPrep Slide in Fine-Needle Aspiration Diagnosis of Medullary Thyroid Carcinoma.
    Ahmed M; Abi-Raad R; Fu L; Holt EH; Adeniran AJ; Cai G
    Am J Clin Pathol; 2022 Mar; 157(3):426-433. PubMed ID: 34596209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis.
    Fuchs TL; Nassour AJ; Glover A; Sywak MS; Sidhu SB; Delbridge LW; Clifton-Bligh RJ; Gild ML; Tsang V; Robinson BG; Clarkson A; Sheen A; Sioson L; Chou A; Gill AJ
    Am J Surg Pathol; 2020 Oct; 44(10):1419-1428. PubMed ID: 32452872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of preoperative cytology for medullary thyroid cancer: Proposal for improved preoperative diagnosis for optimal initial medullary thyroid carcinoma specific surgery.
    Workman AD; Soylu S; Kamani D; Nourmahnad A; Kyriazidis N; Saade R; Ren Y; Wirth L; Faquin WC; Onenerk AM; Nikiforov YE; Al-Qurayshi Z; Kandil E; Kloos RT; Eldeiry L; Lubitz C; Stathatos N; Randolph GW
    Head Neck; 2021 Mar; 43(3):920-927. PubMed ID: 33269526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to the recognition of medullary thyroid carcinoma on FNA: Implications relevant to the new American Thyroid Association guidelines.
    Dyhdalo KS; Chute DJ
    Cancer Cytopathol; 2018 Jun; 126(6):397-405. PubMed ID: 29579362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum calcitonin negative mixed medullary-follicular carcinoma initially diagnosed as medullary thyroid carcinoma by fine-needle aspiration cytology: A case report and review of the literatures.
    Liu Y; Yuan L; Yang D; Jin Y
    Diagn Cytopathol; 2018 Aug; 46(8):690-693. PubMed ID: 29524315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medullary Thyroid Carcinomas Classified According to the International Medullary Carcinoma Grading System and a Surveillance, Epidemiology, and End Results-Based Metastatic Risk Score: A Correlation With Genetic Profile and Angioinvasion.
    Torricelli F; Santandrea G; Botti C; Ragazzi M; Vezzani S; Frasoldati A; Ghidini A; Giordano D; Zanetti E; Rossi T; Nicoli D; Ciarrocchi A; Piana S
    Mod Pathol; 2023 Sep; 36(9):100244. PubMed ID: 37307881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Grade and Molecular Characteristics Associated with Survival in Sporadic Medullary Thyroid Carcinoma.
    Censi S; Galuppini F; Clausi C; Battheu F; Manso J; Piva I; Corvaglia S; Pedron MC; Mondin A; Iacobone M; Torresan F; Merante Boschin I; Bertazza L; Barollo S; Pennelli G; Mian C
    Thyroid; 2024 Feb; 34(2):177-185. PubMed ID: 38047536
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor Grade Predicts for Calcitonin Doubling Times and Disease-Specific Outcomes After Resection of Medullary Thyroid Carcinoma.
    Nigam A; Xu B; Spanheimer PM; Ganly I; Tuttle RM; Wong RJ; Shaha AR; Ghossein RA; Untch BR
    Thyroid; 2022 Oct; 32(10):1193-1200. PubMed ID: 35950622
    [No Abstract]   [Full Text] [Related]  

  • 16. Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma.
    Pankratz DG; Hu Z; Kim SY; Monroe RJ; Wong MG; Traweek ST; Kloos RT; Walsh PS; Kennedy GC
    Thyroid; 2016 Nov; 26(11):1573-1580. PubMed ID: 27605259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medullary thyroid carcinoma diagnosed with liquid-based cytology and immunocytochemistry.
    Nikas IP; Kazamias G; Vrontaki M; Rapti AS; Mastorakis E
    J Immunoassay Immunochem; 2022 Sep; 43(5):502-515. PubMed ID: 35475413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary Thyroid Carcinoma.
    Cavallo AC; Pitoia F; Roberti J; Brenzoni P; Lencioni M; Jaroslavsky MJ; Spengler E; Voogd A; Firpo C; Saco P; Piñero F; Negueruela M
    Thyroid; 2024 Feb; 34(2):186-196. PubMed ID: 38047535
    [No Abstract]   [Full Text] [Related]  

  • 19. An old friend, a new insight: Calcitonin measurement in serum and aspiration needle washout fluids significantly increases the early and accurate detection of medullary thyroid cancer.
    Ogmen BE; Ince N; Aksoy Altınboga A; Akdogan L; Polat SB; Genc B; Menekse E; Aydin C; Topaloglu O; Ersoy R; Cakir B
    Cancer Cytopathol; 2024 Mar; 132(3):161-168. PubMed ID: 37950525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan.
    Suzuki A; Hirokawa M; Takada N; Higuchi M; Ito A; Yamao N; Hayashi T; Kuma S; Miyauchi A
    Endocr J; 2017 Nov; 64(11):1099-1104. PubMed ID: 28883261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.